matrix remodeling proteins, fibroblast proliferation and differentiation into myofibroblasts. 3, 4 To date, the majority of studies evaluating PRP's effects in treating aging facial skin have shown encouraging, though perhaps transient results within weeks of treatment; however, the overall quality of evidence is poor and results vary greatly. This is likely due to variable methods of PRP preparation that yield differing concentrations of platelets and bioactive molecules released from the platelet granules. [4] [5] [6] Different techniques of PRP application can also significantly influence the clinical efficacy of PRP treatment, 7 and currently, there is no accepted number of treatments, or standardized interval between treatments, supported by literature. Furthermore, the absence of uniform, objective outcome metrics precludes cross-study comparisons and limits our ability to draw meaningful conclusions from the current body of literature. Therefore, this single-center prospective pilot study evaluates treatment efficacy and patient-reported satisfaction with a single PRP treatment, prepared using a simple method of PRP preparation that is easily reproducible in clinical practice, without the use of commercial kits.
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| PRP preparation & application
Forty-five minutes prior to the PRP injections, 8 mL of blood was drawn from the antecubital vein of each participant using a 23-gauge butterfly needle (BD Diagnostics, NJ). Blood was collected in 3 tubes (BE Diagnostics, NJ) containing 7.2 mg of ethylenediamine tetraacetic acid (EDTA) each. Samples were centrifuged at 3200 rpm for 5 minutes in a standard laboratory centrifuge (PowerSpin FX, Unico, NJ). After centrifugation, 2 layers were formed over the parser gel and a bottom layer of erythrocytes-a middle layer containing the buffy coat of PRP, and a top layer of platelet-poor plasma (PPP). The yellow fluid of PPP was gently collected using a syringe and set aside. The buffy coat was then collected and combined with enough PPP to produce 4 mL of PRP. Each 8 mL sample of whole blood prepared 4 mL of PRP. No platelet activator was used.
A topical anesthetic cream (lidocaine 2.5% and prilocaine 2.5%) was applied to the patient's face for a period of 15-20 minutes.
Standardized intradermal injections were administered at 6 points on each side of the face (12 total), and were evenly spaced across the inferior border of the cheek and mid-cheek ( Figure 1 ). Each point was injected with 0.33 mL of PRP using a 27-gauge needle, for a total volume of 2 mL per side of the patient's face.
| Evaluation
The 
| Statistical analysis
Modification of the FACE-Q scales precluded analysis via Rasch Measurement Theory; therefore, responses were analyzed on the 1-4 scale (with 1 being "very dissatisfied" and 4 being "very satisfied"), but are presented as either "satisfied" or "dissatisfied."
Severity of side effects of the treatment were scored from not occurring (0) to extremely severe (10), as is typically measured in clinical settings.
Pretreatment and posttreatment scores for each item on the FACE-Q questionnaire were analyzed using the nonparametric test of marginal homogeneity for paired samples data. Per individual subject, "perceived age" at baseline (ie, subject response to the Age Appraisal VAS on the day of their PRP procedure) and "perceived age" at follow-up (ie, subject response to Age Appraisal VAS 5-6 weeks postprocedure) were averaged, as were the pretreatment and posttreatment WSRS scores provided per individual subject by each evaluating physician. These averages were compared using the paired samples t test. Values of P < .05 were considered significant.
Statistical analysis was performed using SPSS (IBM Corp, version 24).
| RESULTS
Thirty-one patients (29 females and 2 males) with Fitzpatrick skin types I through IV completed the study. Median age of the patients was 38 years (ICR, 32-58 years). Median follow-up was 5.7 weeks (IQR, 4.6-6 weeks).
The WSRS scores of only 1 patient changed from a score of 3 at pretreatment to a score of 2 at posttreatment; this was observed by 1 physician evaluator. When evaluated using the GAIS, 14 patients had aesthetic improvement; 17 patients experienced no change. No patients experienced worsening of appearance after treatment with PRP.
Compared to pretreatment FACE-Q scores, patients after PRP treatment had a statistically significant increase in satisfaction with their overall facial appearance and cheeks, based on the FACE-Q Appearance Appraisal Scales (Table 1 ). There was no statistical difference noted in the majority of items on the Quality of Life FACE-Q scales from pretreatment to posttreatment with PRP (Table 2) .
However, subjects did report a statistical decrease in how much they are reminded of how old they look when they see their reflection (mean difference, À0.39; P = .027). On the Age Appraisal VAS, subjects reported themselves appearing (perceiving themselves to look)
an average (SD) of 19.2 (4.70) months younger than their "actual age" at follow-up, compared to appearing only 8.4 (5.38) months (mean difference 10.8 years; 95% CI, À1.6 to À0.05) younger than their "actual age" at baseline (Table 3) .
Using the FACE-Q Process of Care Scales, satisfaction with outcome and decision to undergo PRP treatment was analyzed (Table 3) . The majority of patients reported being "pleased with the result" (74.2%; n = 23) and agreed that "it [was] worth the time and effort" (80.0%; n = 24). However, the majority also reported that the results were not "miraculous" (86.7%; n = 26) or "fantastic" (70.0%; n = 21).
As with any injection-based cosmetic interventions, the PRP treatments had adverse effects ( Table 4 ). The most common early adverse effects reported by patients were tenderness (23.3%; n = 7), and facial tightness (23.3%; n = 7). The early occurring adverse effects were relatively mild, with average severities ranging from 1.9 to 2.5 out of 10. The most common late negative sequelae for skin were parts of the face not looking smooth (63.3%; n = 19), and large pores (60.0%; n = 18). The early adverse effects were more common than earlier occurring ones, but they were mild, ranging in severity from 1.7 to 2.1 out of 10. Anecdotally, subjects reported the injections to be painful, which was reported as being 6 or less on a 1-10 pain scale.
| DISCUSSION
Within their primary role in hemostasis, platelets become activated upon exposure to collagen, triggering the release of the content of their secretory granules. By dispersing hundreds of soluble bioactive proteins, platelets play a critical role in homeostasis, inflammation, immune response, and tissue healing. 8 To harness their activity for therapeutic benefit, these small anucleate cellular fragments are concentrated to supraphysiological levels; however, the efficacy of this technique in aesthetic medicine is controversial despite positive results from numerous dermatologic studies.
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The preparation of PRP introduces a host of variables into stud- How your face looks when you first wake-up?
45 (14) 55 (17) 68 (21) 32 (10) 25 (7) 76 (22) 33 (10) 67 (20) (17) 45 (14) 77 (24) 23 (7) 0.45 (0.16 to 0.75) .008* *Statistically significant (P < .05).
T A B L E 2 FACE-Q quality of life scales

Pretreatment Posttreatment
Mean difference
Aging appearance appraisal I look so old that I don't recognize myself 23 (7) 77 (23) 23 (7) 77 (23 (24) 23 (7) 77 (24) 23 (7) 0.10 (À0.18 to 0.37) .637
I feel great about myself 73 (22) 27 (8) 77 (24) 23 (7) 0.00 (À0.29 to 0.29) 1.0 *Statistically significant (P < .05).
Once preparation of PRP is perfected and better understood, the potential advantages may justify the growing popularity of this technique. However, because translation of in vitro manipulation of each step of preparation into clinical results has proven a challenge, we have proposed an alternate approach. A single centrifugation has been observed as sufficient to activate platelets regardless of anticoagulant use or whether a second centrifugation of plasma was performed. 15 This differs from many of the previously described preparations of PRP, which typically were designed based on anecdotal experience. 20, 21 Instead, we have simplified our preparation of PRP and evaluated its efficacy independent of other therapeutic modalities, using validated outcome measurements of independent physician evaluation and patient-reported satisfaction to eliminate the use of biopsies and other more invasive measures. To minimize potential influence of confounding factors (changes in skin care routine, cosmetic products, diet, sun exposure, etc.), results were assessed at 5-6 weeks, at which points previous studies have observed peak improvement after one treatment.
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Both patient-reported outcomes and objective physician evaluation reveal minimal improvement, which is consistent with previous studies evaluating the effects of one PRP treatment. [21] [22] [23] [24] There was no change in WSRS scores in all but 1 patient. Conversely, the evaluators did note improvement in 14 patients using the GAIS. More Our results show that even a simplified method of PRP preparation and application for aging facial skin has minimal results. Before multiple sessions are considered to be needed for lasting benefit or the results are considered to be transient, future studies should evaluate results at multiple follow-ups. If transient results are observed, the effects of multiple treatments should then be evaluated. We hope this study facilitates comparison of the clinical efficacy of varying methodology in other studies in order to establish the optimal preparation that can be clinically employed for rejuvenating aging facial skin. 
| CONCLUSION
